刺激手腕针点PC6以预防术后恶心和吐:一个网络元分析
Anna Lee1, Jack Zhenhe Zhang1, Jing Xie2,3
1Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
The Cochrane database of systematic reviews
|September 12, 2025
概括
将PC6针点刺激与抗药结合使用可以减少术后恶心和吐 (PONV) 以及救援抗药的需要. 虽然PC6针点刺激可以引起轻微的副作用,但关于其频率和严重性的证据是不确定的.
科学领域:
- 麻醉学和疼痛管理
- 补充和替代医学 补充和替代医学
- 基于证据的医学基于证据的医学.
背景情况:
- 手术后恶心和吐 (PONV) 是手术和麻醉后的常见并发症.
- 目前的抗药物在预防PONV方面只能提供部分有效性.
- 针点PC6刺激是一种替代方案,但其相对有效性尚不清楚.
研究的目的:
- 为了比较PC6针点刺激的疗效和安全性,有或没有抗emetics,与假冒或抗emetics预防PONV.
- 通过网络元分析 (NMAs) 确定用于PONV预防的最有效的技术.
- 更新PC6针点刺激和抗药物组合的现有证据.
主要方法:
- 进行了对多个数据库的系统搜索,搜索到2025年6月的随机对照试验 (RCT).
- 包括RCT比较PC6针点刺激 (侵入性或非侵入性),药物治疗或PONV预防的假干预.
- 进行频率网络元分析 (NMA) 来比较相对影响,并使用CINeMA和GRADE评估证据的确定性.
主要成果:
- 与假药相比,联合的侵入性PC6针点刺激和抗药可能会减少术后恶心 (PON) 和术后吐 (POV).
- 侵袭性和非侵袭性PC6针点刺激,以及单独的抗药,都可能减少PON和POV.
- 结合的非侵入性PC6针点刺激和抗药可能会减少救援抗药的需要;PC6刺激可能会导致轻微的,短暂的副作用.
结论:
- 侵袭性和非侵袭性PC6针点刺激与抗药物相结合,似乎可以有效地减少PON和POV.
- 这些组合也可能减少对救援抗药物的需求.
- 虽然PC6针点刺激可能会产生轻微的副作用,但关于其确定性的证据非常低.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
597
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
597
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
606
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
606
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
817
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
817
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676


